Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07021027 · ClinicalTrials.gov registry record · Early Phase 1
Eggs and Age-related Macular Degeneration (EggsAMD) Study.
A Early Phase 1 study of Intermediate Age-Related Macular Degeneration, sponsored by Kathryn Starr.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07021027 is a Early Phase 1 study of Intermediate Age-Related Macular Degeneration that is actively recruiting participants, run by Kathryn Starr. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07021027, a Early Phase 1 study of Intermediate Age-Related Macular Degeneration, is actively recruiting participants, sponsored by Kathryn Starr.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Age-related macular degeneration (AMD) is the primary cause of vision loss in people over the age of 55. Currently, no cure is available for individuals suffering from AMD. The purpose of this pilot study is to evaluate the feasibility of implementing a 5-month egg intervention in adults with intermediate AMD. The objective of this research study is to evaluate the feasibility of a whole egg (2 or 4 per day) intervention in older adults with intermediate AMD. The secondary objective of this research is to determine descriptive statistics, change over time and estimate effect sizes for retinal sensitivity, and vision, cognition and physical function. By completing these research objectives, the researchers hope to gain preliminary evidence in support of a larger trial that will assess the impact of egg consumption on eye health in adults with AMD.
Conditions Studied
Interventions
- DRUG Whole Egg - 4
- DRUG Whole Egg - 2
Study Locations (1)
North Carolina
- Duke Center for Living - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-06-18 |
| Est. Completion | 2026-09-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07021027
The ClinicalTrials.gov registry entry for NCT07021027 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kathryn Starr, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intermediate Age-Related Macular Degeneration appearing as the primary indexed condition, and to 2 interventions - of which Whole Egg - 4 is the first listed.
NCT07021027 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07021027 about?
NCT07021027 is a clinical study titled "Eggs and Age-related Macular Degeneration (EggsAMD) Study.". Age-related macular degeneration (AMD) is the primary cause of vision loss in people over the age of 55. Currently, no cure is available for individuals suffering from AMD. The purpose of this pilot study is to evaluate the feasibility of implementing a 5-month egg intervention in adults with interm...
What is the current status of trial NCT07021027?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2025-06-18. Estimated completion is 2026-09-30.
What conditions does trial NCT07021027 study?
This clinical trial studies the following conditions: Intermediate Age-Related Macular Degeneration.
What interventions are being tested in trial NCT07021027?
The interventions under investigation include: Whole Egg - 4 (DRUG), Whole Egg - 2 (DRUG).
Who is sponsoring clinical trial NCT07021027?
This trial is sponsored by Kathryn Starr, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07021027 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.